Stratos Wealth Partners’s Zevra Therapeutics ZVRA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.94M | Sell |
220,000
-90,000
| -29% | -$793K | 0.03% | 502 |
|
|
2025
Q1 | $2.32M | Sell |
310,000
-25,840
| -8% | -$194K | 0.04% | 410 |
|
|
2024
Q4 | $2.8M | Sell |
335,840
-82,800
| -20% | -$691K | 0.04% | 390 |
|
|
2024
Q3 | $2.91M | Buy |
418,640
+348,400
| +496% | +$2.42M | 0.04% | 371 |
|
|
2024
Q2 | $344K | Hold |
70,240
| – | – | 0.01% | 1043 |
|
|
2024
Q1 | $407K | Hold |
70,240
| – | – | 0.01% | 970 |
|
|
2023
Q4 | $460K | Buy |
70,240
+40
| +0.1% | +$262 | 0.01% | 901 |
|
|
2023
Q3 | $338K | Hold |
70,200
| – | – | 0.01% | 963 |
|
|
2023
Q2 | $358K | Hold |
70,200
| – | – | 0.01% | 884 |
|
|
2023
Q1 | $386K | Hold |
70,200
| – | – | 0.01% | 779 |
|
|
2022
Q4 | $322K | Hold |
70,200
| – | – | 0.01% | 865 |
|
|
2022
Q3 | $438K | Sell |
70,200
-357
| -0.5% | -$2.23K | 0.01% | 739 |
|
|
2022
Q2 | $315K | Sell |
70,557
-10
| -0% | -$45 | 0.01% | 905 |
|
|
2022
Q1 | $355K | Sell |
70,567
-1,290
| -2% | -$6.49K | 0.01% | 927 |
|
|
2021
Q4 | $626K | Buy |
71,857
+900
| +1% | +$7.84K | 0.01% | 731 |
|
|
2021
Q3 | $662K | Buy |
+70,957
| New | +$662K | 0.02% | 657 |
|
|
2018
Q4 | – | Sell |
-8
| Closed | -$1K | – | 2557 |
|
|
2018
Q3 | $1K | Buy |
+8
| New | +$1K | ﹤0.01% | 2900 |
|
|
2018
Q2 | – | Sell |
-8
| Closed | -$1K | – | 2635 |
|
|
2018
Q1 | $1K | Hold |
8
| – | – | ﹤0.01% | 3049 |
|
|
2017
Q4 | $0 | Buy |
+8
| New | – | ﹤0.01% | 2838 |
|